By 2022, that number had collapsed to 29 percent.
Between 2021 and 2022, Kenya's rotavirus vaccination coverage collapsed from 95 percent to 29 percent — not through neglect of intention, but through the quiet catastrophe of an empty shelf. What had been a functioning shield against infant mortality simply ran out, exposing thousands of children to diseases that a generation of public health work had nearly vanquished. The story of Kenya's immunization crisis is, at its core, a story about the fragility of systems we mistake for permanent — and the cost, measured in vulnerable lives, when those systems are not tended with the same urgency as the emergencies they prevent.
- A 9.8-month rotavirus stockout shattered one of Kenya's strongest vaccination achievements almost overnight, leaving infants exposed to a disease that can kill through dehydration within days.
- By mid-2025, twelve counties had run completely dry across multiple vaccines, with BCG supplies down to two weeks and polio stocks equally precarious — a system-wide failure, not an isolated incident.
- Measles coverage fell to 80 percent, whooping cough and hepatitis B also declined, and Kenya fell below the WHO's 90 percent threshold across several critical categories, widening the population of unprotected children.
- The government doubled the vaccine budget to Sh4.6 billion and launched a Zero-Dose Catch-Up Mechanism, signaling political will — but mid-2026 data shows recovery remains uneven, with some vaccines still slipping.
- International health bodies warn that the true scale of the damage will only be fully visible when revised survey data arrives in 2027, leaving the trajectory of Kenya's immunization recovery genuinely uncertain.
In 2021, Kenya's vaccination program was a quiet success story. Rotavirus coverage — protecting infants against a diarrheal illness that can kill through dehydration — stood at 95 percent. By 2022, it had fallen to 29 percent. The cause was not policy failure or public resistance. The country had simply run out of vaccine.
The shortage lasted nearly ten months at national and regional levels. By March 2026, only around 4,000 doses of rotavirus vaccine remained in the entire country — less than a month's supply. Health officials pointed to manufacturing delays abroad, but the domestic buffer that should have absorbed such disruptions did not exist. The gap in protection was already spreading through the population before the government could respond.
The crisis deepened through 2025. Twelve of Kenya's 47 counties exhausted their stocks entirely. BCG vaccine, which guards against tuberculosis, had two weeks of supply remaining. Measles coverage fell from 92 percent to 80 percent. Polio, whooping cough, and hepatitis B all declined. The World Health Organization's benchmark of 90 percent coverage for basic childhood vaccines was being missed across multiple categories.
The government moved to respond. The National Treasury doubled the vaccine budget to 4.6 billion Kenyan shillings, and health officials announced a Zero-Dose Catch-Up Mechanism to reach children who had missed critical immunization windows. These were substantive commitments — real funding, real programs.
Yet data released in mid-2026 showed a mixed picture. Some vaccines were recovering; others continued to slip. International health organizations noted that many countries had improved their coverage in 2025, while Kenya's performance remained uneven. A fuller accounting will only come when revised survey data is published in 2027. What is already known is that thousands of children spent months unprotected against diseases that can kill quickly — and that the systems meant to prevent exactly this had not held.
In 2021, Kenya's vaccination program was working. Nearly all babies were getting their rotavirus shots—95 percent coverage for the final dose. By 2022, that number had collapsed to 29 percent. The drop was not gradual. It was sudden and severe, driven by a single cause: the country ran out of vaccine.
Rotavirus is not a minor illness. It causes severe diarrhea and vomiting in infants, leading to dangerous dehydration. Without prompt treatment, it kills. The same vulnerability applied to measles, whooping cough, and tuberculosis—all preventable diseases that had been held at bay by a functioning immunization system. Then the system broke.
Global data released by the World Health Organization and Unicef documented what happened. The rotavirus vaccine shortage lasted 9.8 months at national and regional levels. In March 2026, the Ministry of Health announced Kenya had roughly 4,000 doses of Rotavac remaining in the entire country—enough to vaccinate infants for less than a month. Health Cabinet Secretary Aden Duale blamed manufacturing delays at the factory producing the vaccine. The government said it was working to restore supply, but the damage was already spreading through the population.
By June 2025, the crisis had widened. Twelve of Kenya's 47 counties had completely exhausted their vaccine stocks. The BCG vaccine, which protects against tuberculosis, had only two weeks of supply left. The polio vaccine was in similar straits. Across the country, children were missing doses they needed during the critical window when their immune systems were most vulnerable.
The numbers tell the story of a system under strain. Measles vaccine coverage fell from 92 percent in 2019 to 80 percent in 2025. Protection against diphtheria, tetanus, and whooping cough also declined. The World Health Organization's target is 90 percent coverage for all basic childhood vaccines. Kenya was missing that mark in multiple categories. Some vaccines showed slight improvement—BCG coverage edged up to 88 percent from 87 percent—but the overall picture was one of retreat.
The government responded with two moves. The National Treasury doubled the vaccine budget to 4.6 billion Kenyan shillings for the fiscal year beginning in July. Medical Services Permanent Secretary Ouma Oluga announced a "Zero-Dose Catch-Up Mechanism" designed to ensure no child missed a vaccination appointment. These were real commitments, real money, real effort to repair what had broken.
But the latest data, released in mid-2026, showed the recovery was uneven. Some vaccines were improving. Others continued to slip. Gavi, the international organization that supports vaccine access in low-income countries, noted that many nations had improved their coverage in 2025. Kenya's performance was mixed—progress in some areas, decline in others. The organizations cautioned that these figures would likely be revised again when the next report comes out in July 2027, as new survey data becomes available.
What remains clear is that thousands of Kenyan children spent months without protection against diseases that can kill them quickly. The supply chain had failed. The distribution system had failed. The buffer that should have prevented this—adequate stock, redundancy, planning—had not existed. Whether the doubled budget and catch-up programs can restore what was lost, and whether they can prevent it from happening again, will determine whether this becomes a footnote or a turning point.
Notable Quotes
The shortage was caused by delays at the factory that manufactures the vaccine.— Health CS Aden Duale
We have put in place the Zero-Dose Catch-Up Mechanism to ensure no child misses a single dose of any vaccine.— Medical Services PS Ouma Oluga
The Hearth Conversation Another angle on the story
Why did the rotavirus vaccine supply collapse so suddenly between 2021 and 2022?
Manufacturing delays at the factory producing Rotavac. The government didn't have a backup supply or alternative source. When the pipeline broke, there was nothing in reserve.
And the government only found out when they had 4,000 doses left for the entire country?
That's what the March announcement suggests. By then, the shortage had already been happening for months. The system wasn't catching the problem early enough.
What does a 9.8-month stockout actually mean for a parent trying to get their baby vaccinated?
It means you show up at a clinic and they tell you the vaccine isn't there. You come back next month—still nothing. Your baby misses the window when they're supposed to be protected. If they get rotavirus during that gap, they're at serious risk.
The government doubled the budget. Does money alone fix this?
Money helps, but it's not enough. You need better forecasting, better monitoring at the county level, faster procurement processes, and relationships with multiple suppliers so you're not dependent on one factory.
Why should someone outside Kenya care about this?
Because it shows how quickly a vaccination system can fail, even in a country that had achieved high coverage. It's a warning about what happens when supply chains are fragile and oversight is weak.